Skip to navigation Skip to content

News

Share

Society Reaches $250 Million NOW Campaign Goal and Transforms the Pace of MS Research Progress

January 26, 2016

The National MS Society’s groundbreaking $250 million No Opportunity Wasted (NOW) campaign, which successfully concluded in December 2015, has launched more MS research and driven more life-changing progress than has occurred at any other time in the Society’s history.

Since the start of the NOW campaign in 2010, the Society has launched 818 new research projects, including 28 commercial research partnerships aimed at overcoming barriers to commercial development to propel promising new therapies, 71 clinical trials, 141 projects testing rehabilitation and wellness approaches, and 137 grants to train promising MS researchers.

In five short years, the campaign has brought in more than one-quarter of the Society’s total research investments since its founding in 1946, and has accelerated vital research breakthroughs toward stopping the MS in its tracks, restoring what has been lost, and ending MS forever.

Research Progress Focused on Stopping MS includes:
  • Improving tools to speed the diagnosis of MS
  • Supporting promising clinical trials of nerve-protecting strategies
  • Founding the International Progressive MS Alliance
  • Uncovering new evidence for disease progression risk factors
  • Establishing the MS Outcome Assessments Consortium to develop measures of MS progression and speed clinical trials/FDA approval of new therapies
Research Progress Focused on Restoring Lost Function includes:
  • Advancing myelin repair strategies
  • Demonstrating the promise of stem cells to restore function
  • Leveraging wellness research results so that people with MS can apply what we know through research to live their best lives
Research Progress Focused on Ending MS forever includes:
  • Identifying important leads regarding environmental and lifestyle factors that increase MS risk
  • Discovering genes that make people susceptible to MS
  • Establishing and expanding the Network of Pediatric MS Centers
This campaign’s unprecedented investment in research has yielded discoveries that hold great promise for changing lives. The Society is grateful for the contributions of its many generous supporters who have fueled this progress and will continue to focus attention on the issues that matter most to people with MS, and will have the greatest impact.

Learn more about this groundbreaking campaign and its milestones
 

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.

Share